If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.50
Ask: 17.50
Change: -0.50 (-2.86%)
Spread: 1.00 (6.061%)
Open: 17.50
High: 17.50
Low: 17.00
Prev. Close: 17.50
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: STV raises holding in Two Cities Television

Wed, 31st Jan 2024 18:28

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Announces the formal conclusion of the temporary suspension of proceedings process. Anticipates that the court will submit its formal approval of the settlement proposal during the first two weeks of February. Notwithstanding this, it is not considered necessary to seek a further extension to the TSP. Chief Executive David Levi comments: "We are delighted for the company to be able to conclude the TSP process. We exit the TSP on a far stronger financial footing than when we entered, thanks to the encouraging customer contracts and the fundraise we undertook in December.

----------

GreenRoc Mining PLC - UK and Greenland-focused mineral explorer - Announces the successful results of electrochemical battery test work using graphite from its Amitsoq graphite project in southern Greenland, and an update on its processing plant feasibility study. Chief Executive Stefan Bernstein says: "The outcome of this battery test programme is hugely pleasing. This is the first time that graphite material from our Amitsoq project has been tested for its performance within an assembled lithium ion battery cell. These results demonstrate that uncoated purified spherical graphite from Amitsoq performs very well as the active anode material in a battery cell, which is excellent news." Company says that the first and second work phases of the feasibility study are now complete. The next stages of the feasibility study include the design of both a pilot and full-scale processing plant, estimation of production rates, energy requirements and consumables, a full discounted cash flow model for the full-scale processing plant and integrating a risk model.

----------

Somero Enterprises Inc - Fort Myers, Florida-based laser-guided concrete levelling machinery company - Says following good trading and an excellent operational performance in fulfilling customer orders globally during the second half, it expects to report 2023 revenue of USD120.7 million, in line with previous guidance and market expectations. The 2023 revenue expectation reflects the positive impact of the S-22EZ relaunch at full production on trading and a resilient US non-residential construction market. A strong finish to the year was achieved despite ongoing headwinds in the US from concrete supply chain shortages, elevated interest rates and tightened bank lending. In 2024, expects the US market to remain strong, supported by customers reporting high levels of activity and healthy backlogs, continued growth in Europe and Australia, and multiple new product launches. Expects 2024 will be another highly profitable year with healthy cash generation, revenue comparable to 2023, and earnings before interest, tax, depreciation and amortisation that reflects modest incremental investment including the new Belgium service and training centre and the annualized impact of strategic resources added in 2023.

----------

Hummingbird Resources PLC - West Africa-focused and Birmingham, England-based gold producer, developer and explorer - Reports adjusted earnings before interest, tax, depreciation and amortisation in the fourth quarter ending December of USD0.2 million, resulting adjusted Ebitda for 2023 as a whole of USD34.5 million. Yanfolila produced 14,419 ounces of gold in the quarter, with a total of 83,965 oz in 2023, meeting production guidance of 80,000 to 90,000 oz. All in sustaining cost on gold produced at Yanfolila totalled USD1,701 per oz in the quarter, and USD1,361 per oz (in the year compared to USD1,782 per oz in 2022. This met the 2023 AISC guidance of under USD1,500/oz. Group production guidance for 2024 is 165,000 to 200,000 oz at an AISC below USD1,500, which is weighted towards the second half. Expects to spend USD5 million on exploration across both Yanfolila and Kouroussa.

----------

STV Group PLC - Glasgow-based television broadcaster and content producer - Increases its 25% equity stake in the high-end drama production company, Two Cities Television, to a majority holding of 51%. Explains the drama producer has secured revenue of GBP55 million over next 3 years across multiple series. Investment will help underpin Two Cities' growth and strengthen STV Studios' position as leading Nations & Regions producer. STV acquired a minority stake in Two Cities in January 2020, with an option to increase its initial stake to a majority position upon Two Cities becoming profitable.

----------

Botswana Diamonds PLC - Botswana and South Africa-focused diamond explorer - Announces that a consortium including BOD, which is acting as operator with a 30% stake, collectively known as Diamonds of Eswatini Pty Ltd, has been awarded a prospecting license over the diamondiferous Dokowayo kimberlites in Eswatini. Nil consideration was payable by BOD for its 30% interest. The License of just under 4,000 hectares is for an initial period of one year and renewable for a further year. The plan is to undertake an immediate, updated full desktop review and analysis of secondary sources. Following this, bulk sampling of the dumps and kimberlite stockpile is envisaged as the next step forward.

----------

Ariana Resources PLC - mineral exploration and development company with gold mining interests in Turkey, Cyprus and Kosovo - Updates on the 100% owned Asgard Metals Fund, highlighting some of its associated investments. Reports due diligence drilling programme on the Dokwe Gold project in Zimbabwe is ongoing, with the company increasing the current investment in Rockover Holdings to 2.1% by investing a further USD150,000. Highlights increased investment in Panther Metals to circa 5.5%, following an agreement to extend the consulting input of Asgard by a further year to the end of 2024. Notes Pallas Resources agrees an option and joint venture agreement with First Quantum Minerals, whilst securing BHP funding through their Xplor programme.

----------

Destiny Pharma PLC - Brighton, England-based biotechnology company - Announces positive data from a pivotal preclinical safety study of XF-73 Dermal, used for the treatment of antibiotic resistant skin infections associated with open wounds and broken skin. The product was well tolerated with no significant impact on any clinical or safety parameters and had no apparent negative impact on wound healing. Intends initially to progress XF-73 Dermal towards clinical evaluation for the treatment of Diabetic Foot Infections and serious burn wound infections. Further, changes its contract development manufacturing organisation for NTCD-M3 in order to strengthen manufacturing for clinical trial material and improve future commercial supply. These changes mean that the company now expect drug product for the next stage of clinical development to be available in the second half of 2024.

----------

Mobile Streams PLC - London-based mobile content provider - Completes the acquisition of all associated intellectual property for the print and digital operations of Estadio, and Capital Media Group has also transferred and recruited employees to work on the publication. Believes this provides a solid foundation for the relaunch and extension of the brand. Preparations for the launch of the Mexican betting business (in which MOS has a 25% direct shareholding) are well underway and the business is on track to launch early in the second quarter.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
17 Dec 2019 16:06

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Destiny Pharma Says New Guidelines Prove Lead Product Marketability

Read more
2 Dec 2019 15:57

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Destiny Pharma Appoints Former Polyphor Medical Chief To Board

Read more
16 Oct 2019 14:48

Destiny Pharma pleased with latest XF-73 results at it proceeds with next phase

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma reported on the publication of results from a positive phase 1 clinical study in 60 healthy United States volunteers using a nasal gel formulation of its lead drug, XF-73 (exeporfinium chloride), on Wednesday.

Read more
16 Oct 2019 11:36

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Destiny Pharma's XF-73 Associated With Reduced Staphylococcus Aureus

Read more
23 Sep 2019 16:09

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Destiny Pharma Says Non-Executive Joe Eagle Steps Down From Board

Read more
23 Sep 2019 12:12

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Destiny Pharma Interim Loss Narrows On Smaller Share Option Charge

Read more
10 Sep 2019 14:16

Destiny Pharma Collaboration With University Of Sheffield Wins Funding

(Alliance News) - Destiny Pharma PLC on Tuesday said it has been awarded a grant along with the University of Sheffield for their research collaboration on drug-resistant infections.Shares

Read more
9 Apr 2019 11:17

Destiny Pharma Annual Loss Doubles On Higher Costs, Confident Outlook

LONDON (Alliance News) - Destiny Pharma PLC on Tuesday reported a significantly widened annual loss as expenses surged in the run-up to the development of its lead candidate.For 2018, the a

Read more
9 Apr 2019 09:32

Destiny Pharma 'well funded' despite wider loss

(Sharecast News) - Destiny Pharma on Tuesday reported a wider annual loss as it increased research and development costs, although the company is "well funded" through to the second half of next year.

Read more
2 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 3 April AAFull Year ResultsCMC MarketsTrading GroupTrading Year Year 4

Read more
27 Mar 2019 11:53

Destiny Pharma, MedPharm To Develop New XF-Platform Drug Formulations

LONDON (Alliance News) - Destiny Pharma PLC on Wednesday said it has partnered with MedPharm to develop new formulations of its XF-platform compounds.MedPharm is a contract provider of and

Read more
28 Jan 2019 11:46

Destiny Pharma Gets Positive Results From Second Phase Trial Of XF-73

LONDON (Alliance News) - Destiny Pharma PLC on Monday reported positive results in a second phase 1 clinical study examining the anti-irritation features of its XF-73 nasal gel.The study, a

Read more
28 Jan 2019 10:39

Destiny Pharma sees success in latest trial of XF-73 nasal gel

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma announced positive data and the non-irritant classification for its XF-73 nasal gel on Monday.

Read more
25 Jan 2019 10:58

Destiny Pharma leaps on £1.6m grant and UK-China collaboration

(Sharecast News) - Destiny Pharma jumped on Friday after being awarded funding of up to £1.6m from a collaboration established under the UK-China AMR grant fund.

Read more
25 Jan 2019 09:53

Destiny Pharma Gets Funding For Antimicrobial Resistance Research

LONDON (Alliance News) - Destiny Pharma PLC said Friday that it has secured a GBP1.6 million grant for examining novel drugs to prevent, control and eradicate life threatening bacteria or without

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.